Methylphenidate
Methylphenidate is a central nervous system stimulant primarily indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adults, and narcolepsy. It works by blocking the reuptake of dopamine and norepinephrine in the brain, improving focus, attention, and impulse control.
Clinical Overview
Primary Clinical Applications
Methylphenidate is first-line treatment for ADHD across all age groups, with extensive evidence supporting its efficacy in improving attention span, reducing hyperactivity, and enhancing academic and occupational performance. It is also effective for narcolepsy management.
Mechanism and Onset
The medication blocks dopamine and norepinephrine transporters, increasing neurotransmitter availability in the prefrontal cortex. Immediate-release formulations show effects within 30-60 minutes, while extended-release formulations provide 8-12 hours of symptom control.
Formulation Considerations
Multiple formulations are available to optimize dosing convenience and duration of action. Focalin contains only the active d-isomer of methylphenidate, potentially allowing for lower doses with similar efficacy.
Key Clinical Points
Contraindicated with tics or a Tourette's family history
Motor tics, or a family history of Tourette's syndrome, are explicit contraindications. This distinguishes methylphenidate from atomoxetine, which is often chosen for exactly this population.
Focalin is the single active isomer
Dexmethylphenidate contains only the d-isomer, achieving comparable effect at roughly half the milligram dose. Doses are not interchangeable with racemic methylphenidate.
Formulation determines duration
Immediate-release acts within 30 to 60 minutes and needs repeat dosing; extended-release covers 8 to 12 hours once daily. Selection follows the patient's daily schedule.
Boxed warning for abuse and dependence
A Schedule II controlled substance requiring secure storage and attention to diversion, particularly in adolescent and college-age populations.
Growth and cardiovascular monitoring
Track height and weight in children given appetite suppression, and blood pressure and heart rate in all patients. Cardiac evaluation is warranted before initiation.
Prescribing Information
Dosing & Administration
ADHD – Children (6+ years):
- Immediate Release: Start 5 mg twice daily, increase weekly by 5-10 mg increments
- Maximum: 60 mg daily (2 mg/kg/day)
- Extended Release: Start 18-36 mg daily, maximum 72 mg daily
ADHD – Adults:
- Immediate Release: Start 5 mg twice daily, maximum 60 mg daily
- Extended Release: Start 18-36 mg daily, maximum 72 mg daily
Narcolepsy:
- Adults: 10 mg 2-3 times daily, maximum 60 mg daily
Indications
- ADHD in children (6+ years) and adults
- Narcolepsy
Contraindications
- Hypersensitivity to methylphenidate
- Glaucoma
- Motor tics or family history of Tourette’s syndrome
- MAOI use within 14 days
- Severe anxiety, tension, or agitation
Warnings & Precautions
- Boxed Warning: Potential for abuse and dependence
- Cardiovascular monitoring: Blood pressure and heart rate
- Growth suppression in pediatric patients
- Psychiatric adverse reactions: Monitor for mood changes
- Seizure risk in patients with seizure history
Drug Interactions
- MAOIs: Contraindicated – hypertensive crisis risk
- Anticoagulants: May inhibit metabolism
- Antihypertensives: May reduce effectiveness
- Tricyclic antidepressants: Increased levels
Adverse Reactions
Common (>10%):
- Decreased appetite, insomnia, headache, abdominal pain
Cardiovascular:
- Increased blood pressure and heart rate, palpitations
Special Populations
- Pregnancy: Category C – limited human data
- Pediatric: Monitor growth parameters regularly
- Cardiac Disease: Comprehensive cardiac evaluation before initiation
Frequently Asked Questions
What is Methylphenidate used for?
Methylphenidate is a central nervous system stimulant primarily indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adults, and narcolepsy. It works by blocking the reuptake of dopamine and norepinephrine in the brain, improving focus, attention, and impulse control.
What class of drug is Methylphenidate?
Methylphenidate is classified as: CNS Stimulant.
Contraindicated with tics or a Tourette's family history?
Motor tics, or a family history of Tourette's syndrome, are explicit contraindications. This distinguishes methylphenidate from atomoxetine, which is often chosen for exactly this population.
Focalin is the single active isomer?
Dexmethylphenidate contains only the d-isomer, achieving comparable effect at roughly half the milligram dose. Doses are not interchangeable with racemic methylphenidate.
Formulation determines duration?
Immediate-release acts within 30 to 60 minutes and needs repeat dosing; extended-release covers 8 to 12 hours once daily. Selection follows the patient's daily schedule.
Boxed warning for abuse and dependence?
A Schedule II controlled substance requiring secure storage and attention to diversion, particularly in adolescent and college-age populations.
Source: FDA prescribing information (DailyMed)